Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,859,569 papers from all fields of science
Search
Sign In
Create Free Account
EXP-3179
Known as:
EXP 3179
, EXP3179
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Losartan Metabolite EXP 3179 An AT 1-Receptor – Independent Treatment Strategy for Patients With the Metabolic Syndrome ?
G. Rossi
2009
Corpus ID: 19371305
Losartan potassium, the first orally active nonpeptide angiotensin receptor blocker (ARB) to be introduced for clinical use in…
Expand
2009
2009
Protein Kinase C – Inhibiting Properties of the Losartan Metabolite EXP 3179 Make the Difference
P. Wenzel
,
Eberhard Schulz
,
T. Münzel
2009
Corpus ID: 6598786
The inhibition of the renin-angiotensin axis with the angiotensin II (ATII) receptor blockers, such as losartan, candesartan, and…
Expand
2008
2008
Abstract 2468: Chronic Treatment Of Hypertensive Patients With The At1 Receptor Blocker Losartan Results In Sufficient Serum Levels Of The Metabolite Exp3179 Exhibiting Ppar{gamma}-stimulating…
K. Kappert
,
O. Tsuprykov
,
+9 authors
U. Kintscher
2008
Corpus ID: 67883040
2000
2000
Losartan inhibits cyclooxygenase-2-dependent generation of pro-inflammatory and pro-aggregatory prostaglandins via its EXP3179 metabolite
J. Sunkomat
,
C. Kraemer
,
+7 authors
B. Schieffer
2000
Corpus ID: 91956907